AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Learn more →

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

LAAM-HAART PET Imaging

Early Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Radiation: [11c] LAAM
Drug: Ritonavir
Drug: Efavirenz

First Posted Date: 2013-09-05

Last Posted Date: 2017-12-13

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 10

Registration Number: NCT01935830

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Effect of Reducing Uric Acid on Insulin Sensitivity and Oxidative Status

Not Applicable

Completed

Conditions: Obesity
Metabolic Syndrome
Hyperuricemia

Interventions: Drug: Rasburicase

First Posted Date: 2013-08-29

Last Posted Date: 2018-08-14

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 31

Registration Number: NCT01931527

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Efficacy Study of Sitagliptin to Prevent New-onset Diabetes After Kidney Transplant

Phase 4

Completed

Conditions: Posttransplant Diabetes Mellitus

Interventions: Drug: Placebo
Drug: Sitagliptin

First Posted Date: 2013-08-23

Last Posted Date: 2022-12-30

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 61

Registration Number: NCT01928199

Locations: 🇺🇸
Washington University, Saint Louis, Missouri, United States

Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer

Phase 2

Completed

Conditions: Stomach Neoplasms
Esophageal Neoplasms

Interventions: Drug: Irinotecan
Drug: Oxaliplatin
Drug: Trastuzumab
Drug: Leucovorin
Drug: Fluorouracil

First Posted Date: 2013-08-23

Last Posted Date: 2020-08-25

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 67

Registration Number: NCT01928290

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Impact of a Neonatal-Bereavement-Support DVD on Grief

Not Applicable

Completed

Conditions: Grief
Depressive Symptoms

Interventions: Other: DVD Intervention Arm

First Posted Date: 2013-08-20

Last Posted Date: 2025-01-07

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 107

Registration Number: NCT01926080

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Preventing Hypoglycemia

Not Applicable

Completed

Conditions: Diabetes

Interventions: Other: Informatics Alert/Nurse/physician responders

First Posted Date: 2013-08-15

Last Posted Date: 2014-06-20

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 390

Registration Number: NCT01923688

Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic Syndromes

Phase 1

Completed

Conditions: Myelodysplastic Syndromes

Interventions: Drug: vosaroxin
Drug: Azacitidine

First Posted Date: 2013-08-01

Last Posted Date: 2024-05-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 35

Registration Number: NCT01913951

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Cognitive Oriented Strategy Training Augmented Rehabilitation (COSTAR) Treatment Approach for Stroke

Phase 1

Completed

Conditions: Stroke

Interventions: Behavioral: Cognitive-Oriented Strategy Augmented Rehabilitation (COSTAR)
Behavioral: Task Specific Training (TST)

First Posted Date: 2013-07-29

Last Posted Date: 2018-11-28

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 47

Registration Number: NCT01910454

Locations: 🇺🇸
Washington University in St Louis: Program in Occupational Therapy, Saint Louis, Missouri, United States

Disulfiram in Treating Patients With Glioblastoma Multiforme After Radiation Therapy With Temozolomide

Early Phase 1

Completed

Conditions: Glioblastoma

Interventions: Drug: Temozolomide
Drug: Disulfiram
Dietary Supplement: Copper gluconate

First Posted Date: 2013-07-24

Last Posted Date: 2018-07-20

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 21

Registration Number: NCT01907165

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis

Completed

Conditions: Lymphatic Filariasis
Soil Transmitted Helminth Infections

Interventions: Drug: Albendazole (semiannual)
Drug: Albendazole (annual)
Drug: Diethylcarbamazine (semiannual)
Drug: Diethylcarbamazine (annual)

First Posted Date: 2013-07-23

Last Posted Date: 2020-11-17

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 17108

Registration Number: NCT01905423

Locations: 🇮🇩
University of Indonesia, Department of Parasitology, Jakarta, Java, Indonesia

Home Terms & Conditions Privacy Policy